Registr of academic clinical trials

clinical trial, where Masaryk University is the Sponsor

clinical trial, where Masaryk University is the authorized institution of Sponsor and is funded under H2020 or 7FP

clinical trial, where Masaryk University is the authorized institution of Sponsor

 

KDO_DC1311

Combined anticancer therapy with ex vivo manipulated dendritic cells producing interleukin-12 in paediatric, adolescent and young adult patients with progressive, recurrent or primarily metastatic malignancies with high risk

  • The University Hospital Brno, Department of Paediatric Oncology

 

ReNETA

Recurent neuroblastoma and Ewing´s sarcoma: Treosulphan based high dose chemotherapy with autologous PBSC support

 

GabaNeuBol

The influence of preemptive administration of gabapentin on the emergence and development of chronic neuropathic pain in patients after spinal cord trauma  

 

MUV-MEMMAT-01

A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma

  • The University Hospital Brno, Department of Paediatric Oncology, University Hospital in Motol, Department of Paediatric haematology and oncology

 

Dauno Double

Randomized comparison between two dose levels of daunorubicin and between one versus two cycles of induction therapy for adult patients with acute myeloid leukemia ≤60 years

 

Fluorocholin

Diagnostic feasibility and morphologic-functional correlations PET imaging using [18F] -Fluorocholin inj. in patients with prostate cancer

  • Masaryk Memorial Cancer Institute – Department of Urologic Oncology

 

TIGER

Treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukaemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotinib or interferon alpha maintenance therapy

 

STOPRHEA

Prospective clinical trials evaluating the lanreotid effectiveness to reduce chemotherapy-induced diarrhoea in patients with colorectal cancer (STOPRHEA)

  • Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care

 

SIOP PNET 5 MB

An International prospective study on clinically standard-risk medulloblastoma in children older than 3 to 5 years with low-risk biological profile (PNET 5 MB –LR) or average-risk biological profile (PNET 5 MB – SR) NTERNATIONAL

 

Ependymoma II

An international Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma, a phase II study

  • The University Hospital Brno, Department of Paediatric Oncology, University Hospital in Motol, Department of Paediatric haematology and oncology

 

2016-1-DSF-MBC

Phase II open labeled trial of disulfiram with copper in metastatic breast cancer

  • University hospital Olomouc, Department of Oncology

 

CELLIMIN

Prospective donor-specific Cellular alloresponse assessment for Immunosuppression Minimization in de novo renal transplantation

 

POEM_H2020

Endoscopic versus Laparoscopic Myotomy for Treatment of Idiopathic Achalasia: A Randomized, Controlled Trial

  • Institute for Clinical and Experimental Medicine, Department of Hepatogastroenterology

 

FAIRPARK II_H2020

Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease. It’s a European multicentre, parallel-group, placebo-controlled, randomized clinical trial of deferiprone (DFP)

 

DISCHARGE_7FP

Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies ty

 

EuroHYP_7FP

European multicentre, randomised, phase III clinical trial of hypothermia plus bestmedical treatment versus best medical treatment alone for acute ischaemic stroke

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

K personalizaci obsahu, poskytování funkcí sociálních médií a analýze naší návštěvnosti využíváme soubory cookie.

Používáním webu s tím souhlasíte.

Zásady ochrany osobních údajů

  • LinkedIn - Gray Circle
  • Facebook - Grey Circle